HBV infection rates are on the rise

Estimated new cases of HBV in the US9,10

New cases of HBV are increasing New cases of HBV are increasing

Compliance challenges with existing HBV vaccines may potentially leave patients at risk

Only 54% of adults completed a hepatitis B vaccine Only 54% of adults completed a hepatitis B vaccine

There is no cure for hepatitis B. Effective vaccination is critical to reducing the spread of the disease15

*Calculation based on a weighted average of patients aged 18 years or older (n=88,711) initiating a hepatitis B vaccination series in a large population-based, retrospective cohort study of the Vaccine Safety Datalink population of approximately 8.8 million Medical Care Organization enrollees.14

CDC=Centers for Disease Control and Prevention.



Burden Of Disease — Rates of HBV
HEPLISAV-B Hepatitis B Vaccine (Recombinant), Adjuvantedâ„¢ HEPLISAV-B Hepatitis B Vaccine (Recombinant), Adjuvantedâ„¢

Thank you for your submission. An automated email containing the Enrollment Letter will be sent to you shortly.

Call 1-84-HEPLISAV (1-844-375-4728)
8 AM to 8 PM, ET, Monday through Friday